Quick Answer
Hepion Pharmaceuticals, Inc. reported Stockholders Equity of $2.67 million for fiscal year 2025.
Hepion Pharmaceuticals, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $2.67M | +243.2% |
| 2024 | -$1.86M | -125.6% |
| 2023 | $7.28M | -85.4% |
| 2022 | $49.86M | -46.4% |
| 2021 | $93.00M | -9.4% |
| 2021 | $102.64M | -7.3% |
| 2021 | $110.72M | -5.8% |
| 2021 | $117.58M | +190.2% |
| 2020 | $40.52M | +159.5% |
| 2019 | $15.62M | +805.4% |
| 2018 | $1.72M | -53.4% |
| 2017 | $3.70M | -59.1% |
| 2017 | $9.06M | +587.5% |
| 2016 | $1.32M | -61.7% |
| 2015 | $3.44M | +217.2% |
| 2014 | -$2.93M | -1987.7% |
| 2013 | -$140.5K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.32M | +717.4% | -12.4% |
| June 30, 2025 | $3.80M | +6.6% | -2.5% |
| March 31, 2025 | $3.90M | -48.2% | +309.1% |
| December 31, 2024 | -$1.86M | -125.6% | -558.2% |
| September 30, 2024 | $406.7K | -97.5% | -88.6% |
| June 30, 2024 | $3.56M | -86.5% | -52.6% |
| March 31, 2024 | $7.52M | -79.8% | +3.3% |
| December 31, 2023 | $7.28M | -85.4% | -54.9% |
- Hepion Pharmaceuticals, Inc. showed an increase of +243.2% in Stockholders Equity compared to the prior fiscal year.
- Over the 2013–2025 period, Hepion Pharmaceuticals, Inc.’s stockholders equity has grown by 1998.7% (from -$140.5 thousand to $2.67 million).
- The most recent figure is from Hepion Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: